Small Cell Lung Cancer Extensive Stage
1 competing product in clinical development for Small Cell Lung Cancer Extensive Stage.
Pipeline by Phase
Phase 1/21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Gocatamig + I-DXd + Atezolizumab + Carboplatin + Etoposide + Rescue Medications | Daiichi Sankyo | Phase 1/2 | Recruiting | 39 |